The CHU Laboratory of Cell and Gene Therapy (LTCG) has developed a strong expertise in basic research on in vitro and murine models, in the production of cellular product batches (ATMP) and in running related phase I/II clinical trials.
The LTCG consists of:
- 3 FAMHP-approved tissue banks (hematopoietic cells, cord blood, non-hematopoietic cells) and a GMP facility offering services like cell collection (from patients or normal volunteers), processing, storage and distribution
- R&D unit to transfer innovative cell technologies to the clinic
- ATMP production lab producing and distributing cell products used in patients in the context of approved clinical trials
Contact [info@b2h.be] us to discuss how these capabilities can forward your projects! We will help you develop tailored solutions.